Wave of new commitments marks historic step towards the elimination of cervical cancer

Governments, donors, and international organizations have pledged significant new commitments totaling nearly US$600 million to combat cervical cancer, marking a pivotal moment in the fight against this preventable disease. The announcements were made at the inaugural Global Cervical Cancer Elimination Forum held in Cartagena de Indias, Colombia. The forum, attended by experts and stakeholders from…

Experts Raise Concerns Over Blood Wastage at Africa Society for Blood Trsnsfusion Congress in Uganda

Experts at the Africa Society for Blood Transfusion (AfSBT) congress in Munyonyo are raising concerns about blood wastage in hospitals, highlighting the need for proper stock management and optimal blood utilization practices. The World Health Organization (WHO) reports that while developed countries have a blood wastage rate between 0.1% and 6.7%, there is limited information…

SynaptixBio Earns Second FDA Orphan Drug Designation for Rare Disease Treatment

  SynaptixBio, a prominent biotech firm dedicated to combating rare and deadly diseases, has achieved a significant milestone by securing a second Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA).   The company’s initial ODD, obtained in early 2023, targeted Hypomyelination with Atrophy of the Basal ganglia and Cerebellum (H-ABC), the…